TIGIT and PD-1 impair tumor antigen–specific CD8(+) T cells in melanoma patients

Схожие документы

• CD226 opposes TIGIT to disrupt Tregs in melanoma
  по: Fourcade, Julien, et al.
  Опубликовано: (2018)
• IL-10 and PD-1 cooperate to limit the activity of tumor-specific CD8(+) T cells
  по: Sun, Zhaojun, et al.
  Опубликовано: (2015)
• CD8+ T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1
  по: Fourcade, Julien, et al.
  Опубликовано: (2011)
• Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8(+) T cell dysfunction in melanoma patients
  по: Fourcade, Julien, et al.
  Опубликовано: (2010)
• PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8+ T cells induced by melanoma vaccines
  по: Fourcade, Julien, et al.
  Опубликовано: (2013)